Point72 Hong Kong LTD Revance Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $76,677 - $135,782	6,656 New	6,656 $92,000
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $2,217 - $4,960	-178 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $156,329 - $201,385	-6,064 Reduced 97.15%	178 $5,000
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $151,554 - $180,055	5,655 Added 963.37%	6,242 $185,000
Q1 2021 May 17, 2021	BUY	$24.03 - $29.97 $14,105 - $17,592	587 New	587 $16,000
Q4 2020 Feb 16, 2021	SELL	$23.41 - $28.34 $16,691 - $20,206	-713 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $16,562 - $24,455	713 New	713 $18,000
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $2,948 - $6,212	-234 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $21,393 - $47,749	-1,717 Reduced 88.01%	234 $3,000
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $22,748 - $39,312	1,951 New	1,951 $32,000
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $1,829 - $2,595	-179 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $1,909 - $2,772	179 New	179 $2,000
Q2 2018 Aug 14, 2018	SELL	$27.45 - $33.35 $14,823 - $18,009	-540 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.15 - $37.4 $15,741 - $20,196	540 New	540 $17,000

226

82.9M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.